Live Breaking News & Updates on பாரத் பயோடெக் லிமிடெட்

Stay updated with breaking news from பாரத் பயோடெக் லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Brazil suspends clinical trials of Covaxin after termination of agreement


Brazil has suspended the clinical studies of Bharat Biotech s COVID-19 vaccine, Covaxin following termination of the company s agreement with its partner there, the South American Country s health regulator said.
Bharat Biotech on Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for the Brazilian market.
The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.
In The Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studies of the Covaxin vaccine in Brazil ....

United States , Precisa Medicamentos , Medicamentos Ltda , Coordination Of Clinical Research At Anvisa Copec , Bharat Biotech Ltd , Bharat Biotech Limited International , Envixia Pharmaceuticals , Bharat Biotech , South American Country , Clinical Research , Precise Comercializao De Medicamentos , ஒன்றுபட்டது மாநிலங்களில் , பாரத் பயோடெக் லிமிடெட் , பாரத் பயோடெக் , தெற்கு அமெரிக்கன் நாடு , மருத்துவ ஆராய்ச்சி ,